Peptide

BRP

Also known as

BRINP2-related peptide · BRINP2 related peptide · BRINP-2 · BRINP2 · THRILRRLFNLC · Stanford BRP · natural Ozempic peptide

Community talk. May contain inaccuracies. Not medical advice. Not a protocol. Not for human or animal use.

What it is

Appetite research peptide	BRINP2-related peptide is a 12-amino-acid fragment studied for reducing food intake in animals through a pathway separate from GLP-1 receptors.
Natural Ozempic nickname	The nickname drives interest but does not make BRP equivalent to semaglutide or verify a supplied product.

Notes

A small fragment of the BRINP2 protein. BRP means BRINP2-related peptide, sequence THRILRRLFNLC. Animal findings link this 12-amino-acid chain to appetite signaling in the hypothalamus, a brain region, independently of GLP-1 receptors. It is not semaglutide or MOTS-c. Coassolo et al. — Prohormone cleavage prediction uncovers a non-incretin anti-obesity peptide (Animal context · Accessed 2026-09-30) · BRP (BRINP2-related peptide) (Community discussion · Accessed 2026-09-30)

‘Natural Ozempic’ is a nickname, not an equivalence. Retatrutide discussants disagree about the headline: one finds BRP promising, others distrust the no-side-effects pitch. A reply points out that naturally occurring signaling peptides and engineered medicines are different things. The name alone says nothing about a supplied product’s identity or effects. For those interested. A new peptide being studied. (Community discussion · Accessed 2026-09-30) · Weight Loss Breakthrough: Stanford Scientists Discover ‘Natural Ozempic’ Without the Side Effects (Community opinion · Accessed 2026-09-30)

Source context — Coassolo et al. — Prohormone cleavage prediction uncovers a non-incretin anti-obesity peptide: Abstract and figure captions inspected, not full methods. Mouse and minipig findings are not human effectiveness, dosing or felt timing. This is the same original study as Nature DOI 10.1038/s41586-025-08683-y and Stanford's 2025 news; do not count copies as independent trials.

Source context — BRP (BRINP2-related peptide): Prospective two-week daily plan plus claimed supply, no quantity, route, identified stack or completed outcome. The OP's literature summary traces to one 2025 paper; it is not independent experimental corroboration. Relative age was displayed, exact publication date not confirmed.

Source context — For those interested. A new peptide being studied.: Discovery discussion, subjective preference and skepticism; no firsthand BRP use. Shared headline derives from Stanford reporting. Claims that drugs without adverse effects have no effects are opinions, not accepted scientific principles.

Source context — Weight Loss Breakthrough: Stanford Scientists Discover ‘Natural Ozempic’ Without the Side Effects: Selected visible discussions, not every comment or a prevalence sample. These are opinions about headlines and discovery, not BRP use reports. No health-outcome anecdotes from other drugs were relabeled as BRP.

What people notice

Hoped-for effects	Less food noise, fat loss and fewer digestive problems attract interest. The inspected threads contain expectations, not completed human BRP outcomes.
Other-drug experiences	Constipation and returning food thoughts in these discussions concern earlier treatments or existing symptoms, rather than a reaction or response to BRP.

Notes

Quieter food noise without feeling backed up. In one Retatrutide thread, a person with IBS described constipation and returning food thoughts after tirzepatide and retatrutide, then found BRP while searching for a different option. Their BRP comment quotes a claim about avoiding digestion delays; it does not say they took BRP or improved on it. Food noise maximizing (Community discussion · Accessed 2026-09-30)

Fat loss with less nausea and less muscle loss. Those are the attractions repeated in the Ozempic discussion and existing peptide notes. They come from animal findings, not demonstrated human benefits. A commenter’s distressing constipation history concerns their existing situation, not an adverse reaction to BRP. Stanford's Natural Ozempic: BRP Peptide Study Explained (Community discussion · Accessed 2026-09-30)

A cleaner side-effect story still needs human experience. Ozempic readers welcome the possibility of fewer digestive problems, while a reply emphasizes mice and minipigs. Technology commenters question whether ‘without the side effects’ means without any side effects. No inspected BRP log supplies positive, unchanged or adverse human outcomes to settle that distinction. Stanford's Natural Ozempic: BRP Peptide Study Explained (Community discussion · Accessed 2026-09-30) · Weight Loss Breakthrough: Stanford Scientists Discover ‘Natural Ozempic’ Without the Side Effects (Community opinion · Accessed 2026-09-30)

Source context — Food noise maximizing: One account with digestive symptoms, earlier weight loss and returning food noise on other compounds; the BRP text is a quoted promotional-sounding claim with no original linked source. No claimed BRP use. Replies recommending cagrilintide are not BRP protocols. All OP replies are one person, not corroboration.

Source context — Stanford's Natural Ozempic: BRP Peptide Study Explained: News-sharing and expectations; animal findings repeat the Stanford paper family, not an independent study. The constipation reply does not say BRP was used. Exact date appears in indexed post metadata, current body uses relative age.

Doses people talk about

Human amounts	No completed human amount, route or daily total is supplied by the inspected threads. The proposed two-week experiment gives no milligrams.
Separate mouse experiments	5 mg/kg in lean mice, 10 mg/kg in obese mice and a 20 mg/kg acute dose-response used abdominal-cavity injections. These are animal amounts.
Repeated mouse arm	5 mg/kg daily for 14 days was a different obese-mouse experiment, not a human schedule.

Notes

No completed human dose report in the inspected threads. The prospective two-week post gives no milligrams per administration, daily total or injection route. Subcutaneous research-vial talk remains in the existing record, but it is not a documented human dose range. Animal mg/kg figures and commercial charts cannot supply that missing answer. BRP (BRINP2-related peptide) (Community discussion · Accessed 2026-09-30)

Mouse quantities are separate experiments. The preserved extraction describes separate intraperitoneal, or abdominal-cavity, mouse injections: 5 mg/kg in lean mice, 10 mg/kg in obese mice and 20 mg/kg in an acute dose-response experiment. A different obese-mouse arm used 5 mg/kg daily for 14 days. These study conditions do not establish human regimens. Coassolo et al. — Prohormone cleavage prediction uncovers a non-incretin anti-obesity peptide (Animal context · Accessed 2026-09-30) · Coassolo et al. — preserved BRP form, dose-response and mouse timing extraction (Animal context · Accessed 2026-09-30)

Source context — Coassolo et al. — preserved BRP form, dose-response and mouse timing extraction: Re-read the exact canonical extraction now; original extraction was reviewed 2026-09-06. Nature returned Internal Error and PMC displayed reCAPTCHA in this run. Tail modification, 20 mg/kg detail and under-10-minute estimate were not freshly confirmed in full text. Formal animal provenance remains explicit; this source is not a community measurement or a new study.

Half-life, onset & duration

Felt onset	No human first-meal, first-day or first-week onset is reported in these threads.
Felt duration	Human hunger-suppression duration and what happens after stopping remain unreported here.
Half-life	Human half-life is unknown in this record. Under 10 minutes is a preserved mouse estimate after abdominal-cavity injection, not human SubQ kinetics.
Animal blood peak	One minute in the preserved lean-mouse extraction at 5 and 10 mg/kg; this is not human felt onset.

Notes

No reported human onset to time. Posts repeat rapid appetite changes in animals but supply no BRP user account of the first meal, first day or first week. An animal feeding window does not tell a person when hunger, food noise or digestive symptoms would change. BRP (BRINP2-related peptide) (Community discussion · Accessed 2026-09-30) · Stanford's Natural Ozempic: BRP Peptide Study Explained (Community discussion · Accessed 2026-09-30)

Single-use effects and after-stopping effects remain unreported. The threads do not describe how long BRP suppresses human hunger or whether it returns differently after stopping. The existing record likewise has no withdrawal history. Neither a two-week plan nor an animal experiment measures a human benefit’s duration. BRP (BRINP2-related peptide) (Community discussion · Accessed 2026-09-30)

Human half-life is unknown in this community record. The opened discussions offer no measured human value. A short animal blood-level estimate is not a human or subcutaneous estimate, and semaglutide’s long half-life does not transfer to BRP. Half-life describes falling concentration, not how long someone feels less hungry. BRP (BRINP2-related peptide) (Community discussion · Accessed 2026-09-30) · For those interested. A new peptide being studied. (Community discussion · Accessed 2026-09-30)

Under 10 minutes is a preserved mouse blood estimate. After abdominal-cavity injection, the extraction records a one-minute blood peak in lean male mice at 5 and 10 mg/kg, none detectable at 0.5 mg/kg, and half-life under 10 minutes. Human timing remains unknown. Coassolo et al. — preserved BRP form, dose-response and mouse timing extraction (Animal context · Accessed 2026-09-30)

Cycles people discuss

One proposed experiment	Two weeks daily appears as a plan to add BRP to an existing stack. No completed outcome or time-off schedule follows in the visible replies.

Notes

Two weeks daily appears as one proposed experiment. The NTNPerformance author asks for experiences before a planned addition to an existing stack. No completion, outcome or time-off schedule follows in the visible replies. This is intent, not an established cycle, and it does not justify copying a weekly GLP-1 schedule. BRP (BRINP2-related peptide) (Community discussion · Accessed 2026-09-30)

Stacks

Speculative combinations	ATX-304 and MOTS-c appear in speculative combination talk, without a completed BRP stack outcome.
Unnamed planned stack	The prospective two-week author did not identify the other ingredients. Comparisons with semaglutide or retatrutide are not reports of combining them.

Notes

ATX-304 and MOTS-c: These names appear in speculative metabolic combinations, without a completed BRP outcome or validated schedule. [community]

Stack suggestions have no BRP outcome history behind them. The existing discussion includes comparisons with semaglutide and retatrutide, plus speculative combinations with ATX-304 or MOTS-c. It contains no completed combination account showing benefit or interactions. The new prospective stack post does not identify its other ingredients. BRP (BRINP2-related peptide) (Community discussion · Accessed 2026-09-30)

Semaglutide and retatrutide comparisons: The discussions compare expectations and prior drug experiences. They do not document a completed combination with BRP or establish its interaction profile. [community]

Watch for

Human safety unanswered	The saved institutional interview described BRP as not yet human-tested. These records do not settle interactions, pregnancy effects or long-term safety.
Chemical form matters	The paper extraction distinguishes active amidated BRP from inactive non-amidated BRP. A name, sequence or certificate does not establish product equivalence or injection suitability.

Notes

A research product is not the Stanford development program. An August 2026 Stanford interview says BRP had not been tested in humans and describes unregulated products appearing online. Human safety, interactions, pregnancy effects and long-term use remain unanswered here. A ‘natural’ label or feeling fine cannot resolve those gaps. Stanford Medicine — Peptides are buzzing: But what does the science say? (Official context · Accessed 2026-09-30)

The peptide’s chemical form matters. Amidation changes the chain’s end. The preserved paper extraction describes active amidated BRP and inactive non-amidated BRP. A sequence or certificate cannot establish product equivalence or injection suitability. Coassolo et al. — preserved BRP form, dose-response and mouse timing extraction (Animal context · Accessed 2026-09-30)

Source context — Stanford Medicine — Peptides are buzzing: But what does the science say?: Institutional interview dated August 10, not a September 30 trial-registry audit. General peptide risks do not prove a BRP-specific adverse event. Human pregnancy and interaction data are not supplied. Source has institutional research interests; no whole-category claim of safety is adopted.

Full notes

BRP is an experimental appetite peptide discussed as a possible way to reduce hunger without the digestive problems associated with GLP-1 drugs. The nickname ‘natural Ozempic’ drives interest, but the opened discussions contain expectations and plans rather than completed BRP experience logs.

What BRP actually is

A small fragment of the BRINP2 protein. BRP means BRINP2-related peptide, sequence THRILRRLFNLC. Animal findings link this 12-amino-acid chain to appetite signaling in the hypothalamus, a brain region, independently of GLP-1 receptors. It is not semaglutide or MOTS-c. Animal context Reddit · r/NTNPerformance Community
‘Natural Ozempic’ is a nickname, not an equivalence. Retatrutide discussants disagree about the headline: one finds BRP promising, others distrust the no-side-effects pitch. A reply points out that naturally occurring signaling peptides and engineered medicines are different things. The name alone says nothing about a supplied product’s identity or effects. Reddit · r/Retatrutide Reddit · r/technology

What people hope to get from it

Quieter food noise without feeling backed up. In one Retatrutide thread, a person with IBS described constipation and returning food thoughts after tirzepatide and retatrutide, then found BRP while searching for a different option. Their BRP comment quotes a claim about avoiding digestion delays; it does not say they took BRP or improved on it. Reddit · r/Retatrutide
Fat loss with less nausea and less muscle loss. Those are the attractions repeated in the Ozempic discussion and existing peptide notes. They come from animal findings, not demonstrated human benefits. A commenter’s distressing constipation history concerns their existing situation, not an adverse reaction to BRP. Reddit · r/Ozempic Community

Doses people discuss

No completed human dose report in the inspected threads. The prospective two-week post gives no milligrams per administration, daily total or injection route. Subcutaneous research-vial talk remains in the existing record, but it is not a documented human dose range. Animal mg/kg figures and commercial charts cannot supply that missing answer. Reddit · r/NTNPerformance Community

Half-life

Human half-life is unknown in this community record. The opened discussions offer no measured human value. A short animal blood-level estimate is not a human or subcutaneous estimate, and semaglutide’s long half-life does not transfer to BRP. Half-life describes falling concentration, not how long someone feels less hungry. Reddit · r/NTNPerformance Reddit · r/Retatrutide Community

Onset: when a change is noticed

No reported human onset to time. Posts repeat rapid appetite changes in animals but supply no BRP user account of the first meal, first day or first week. An animal feeding window does not tell a person when hunger, food noise or digestive symptoms would change. Reddit · r/NTNPerformance Reddit · r/Ozempic

Duration: how long a change lasts

Single-use effects and after-stopping effects remain unreported. The threads do not describe how long BRP suppresses human hunger or whether it returns differently after stopping. The existing record likewise has no withdrawal history. Neither a two-week plan nor an animal experiment measures a human benefit’s duration. Reddit · r/NTNPerformance Community

Cycles and time off

Two weeks daily appears as one proposed experiment. The NTNPerformance author asks for experiences before a planned addition to an existing stack. No completion, outcome or time-off schedule follows in the visible replies. This is intent, not an established cycle, and it does not justify copying a weekly GLP-1 schedule. Reddit · r/NTNPerformance Community

Good to know

A research product is not the Stanford development program. An August 2026 Stanford interview says BRP had not been tested in humans and describes unregulated products appearing online. Human safety, interactions, pregnancy effects and long-term use remain unanswered here. A ‘natural’ label or feeling fine cannot resolve those gaps. Official context
The peptide’s chemical form matters. Amidation changes the chain’s end. The preserved paper extraction describes active amidated BRP and inactive non-amidated BRP. A sequence or certificate cannot establish product equivalence or injection suitability. Animal context Community
Stack suggestions have no BRP outcome history behind them. The existing discussion includes comparisons with semaglutide and retatrutide, plus speculative combinations with ATX-304 or MOTS-c. It contains no completed combination account showing benefit or interactions. The new prospective stack post does not identify its other ingredients. Community Reddit · r/NTNPerformance

From community discussion

Claimed possession and proven experience are different. One NTNPerformance reply doubts BRP is available. The original author says they have a small supply and calls it expensive. Neither statement verifies the material, and the replies do not report taking it. That exchange explains the availability disagreement without treating a supply claim as an outcome. Reddit · r/NTNPerformance
Interest can coexist with preferring another compound. The Retatrutide thread’s author shares the discovery but still prefers reta. Another reply calls BRP promising, while others question the ‘natural’ branding. These are opinions about an emerging candidate, not a comparison trial or evidence that BRP failed for those commenters. Reddit · r/Retatrutide
A cleaner side-effect story still needs human experience. Ozempic readers welcome the possibility of fewer digestive problems, while a reply emphasizes mice and minipigs. Technology commenters question whether ‘without the side effects’ means without any side effects. No inspected BRP log supplies positive, unchanged or adverse human outcomes to settle that distinction. Reddit · r/Ozempic Reddit · r/technology

Supporting context: animal numbers

Mouse quantities are separate experiments. The preserved extraction describes separate intraperitoneal, or abdominal-cavity, mouse injections: 5 mg/kg in lean mice, 10 mg/kg in obese mice and 20 mg/kg in an acute dose-response experiment. A different obese-mouse arm used 5 mg/kg daily for 14 days. These study conditions do not establish human regimens. Animal context Animal context
Under 10 minutes is a preserved mouse blood estimate. After abdominal-cavity injection, the extraction records a one-minute blood peak in lean male mice at 5 and 10 mg/kg, none detectable at 0.5 mg/kg, and half-life under 10 minutes. Human timing remains unknown. Animal context